Ablation of the ID2 gene results in altered circadian feeding behavior, and sex-specific enhancement of insulin sensitivity and elevated glucose uptake in skeletal muscle and brown adipose tissue. by Mathew, D et al.
Ablation of the Id2 Gene Results in Altered Circadian
Feeding Behavior, and Sex-Specific Enhancement of
Insulin Sensitivity and Elevated Glucose Uptake in
Skeletal Muscle and Brown Adipose Tissue
Deepa Mathew1, Peng Zhou1, Cameron M. Pywell1, Daan R. van der Veen1¤a, Jinping Shao1¤b, Yang Xi1,
Nicolle A. Bonar1, Alyssa D. Hummel1, Sarah Chapman2, W. Matthew Leevy1,2, Giles E. Duffield1,3*
1Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America, 2Notre Dame Integrated Imaging Facility, University of
Notre Dame, Notre Dame, Indiana, United States of America, 3 Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America
Abstract
Inhibitor of DNA binding 2 (ID2) is a helix-loop-helix transcriptional repressor rhythmically expressed in many adult tissues.
Our earlier studies have demonstrated a role for ID2 in the input pathway, core clock function and output pathways of the
mouse circadian system. We have also reported that Id2 null (Id22/2) mice are lean with low gonadal white adipose tissue
deposits and lower lipid content in the liver. These results coincided with altered or disrupted circadian expression profiles
of liver genes including those involved in lipid metabolism. In the present phenotypic study we intended to decipher, on a
sex-specific basis, the role of ID2 in glucose metabolism and in the circadian regulation of activity, important components of
energy balance. We find that Id22/2 mice exhibited altered daily and circadian rhythms of feeding and locomotor activity;
activity profiles extended further into the late night/dark phase of the 24-hr cycle, despite mice showing reduced total
locomotor activity. Also, male Id22/2 mice consumed a greater amount of food relative to body mass, and displayed less
weight gain. Id22/2 females had smaller adipocytes, suggesting sexual-dimorphic programing of adipogenesis. We
observed increased glucose tolerance and insulin sensitivity in male Id22/2 mice, which was exacerbated in older animals.
FDG-PET analysis revealed increased glucose uptake by skeletal muscle and brown adipose tissue of male Id22/2 mice,
suggesting increased glucose metabolism and thermogenesis in these tissues. Reductions in intramuscular triacylglycerol
and diacylglycerol were detected in male Id22/2 mice, highlighting its possible mechanistic role in enhanced insulin
sensitivity in these mice. Our findings indicate a role for ID2 as a regulator of glucose and lipid metabolism, and in the
circadian control of feeding/locomotor behavior; and contribute to the understanding of the development of obesity and
diabetes, particularly in shift work personnel among whom incidence of such metabolic disorders is elevated.
Citation: Mathew D, Zhou P, Pywell CM, van der Veen DR, Shao J, et al. (2013) Ablation of the Id2 Gene Results in Altered Circadian Feeding Behavior, and Sex-
Specific Enhancement of Insulin Sensitivity and Elevated Glucose Uptake in Skeletal Muscle and Brown Adipose Tissue. PLoS ONE 8(9): e73064. doi:10.1371/
journal.pone.0073064
Editor: Paul A. Bartell, Pennsylvania State University, United States of America
Received April 26, 2013; Accepted July 15, 2013; Published September 2, 2013
Copyright:  2013 Mathew et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported from grants to GED from the NIGMS (R01-GM087508) and American Heart Association (10SDG4030011), and from a University
of Notre Dame College of Science Summer Undergraduate Research Fellowship (to CMP). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: duffield.2@nd.edu
¤a Current address: Department of Biochemistry and Physiology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, United Kingdom
¤b Current address: Department of Anatomy, Basic Medical College, Zhengzhou University, Zhengzhou, People’s Republic of China
Introduction
Inhibitor of DNA binding 2 (ID2) is a dominant negative
regulator of basic helix-loop-helix (bHLH) transcription factors,
which acts by heterodimerizing with them and inhibiting their
ability to bind to E-box elements within target gene promoters
[1,2]. A functional role of ID2 has been demonstrated in cell
lineage determination, cell cycle progression, adaptive immunity
and tumorigenesis [1,2]. Id2 is expressed in a many adult tissues
and shows circadian rhythmicity in its RNA and protein
expression [3,4].
Circadian rhythms are cyclical occurrences of physiological
and/or behavioral events with a periodicity of ,24 hrs, exhibited
by all eukaryotic organisms [5]. This intrinsic time keeping
mechanism is believed to have evolved as an adaptive response to
the daily changes in the surrounding environment such as light
and food availability. This enables organisms to anticipate such
changes and coordinate, or temporally partition, different
biological processes for optimal utilization of resources. In
mammals the master circadian oscillator resides in the hypotha-
lamic suprachiasmatic nuclei (SCN). The SCN synchronizes and
phase resets the cell autonomous clock mechanisms in the
peripheral tissues through humoral signals, autonomic innerva-
tion, body temperature and feeding related cues [6]. At the
molecular level, the clock is encoded by transcriptional-transla-
tional autoregulatory feedback loops of core clock proteins. The
positive loop is composed of bHLH-PAS transcriptional activators
CLOCK (or NPAS2) and BMAL1. They heterodimerize and
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transactivate a proportion of the downstream clock controlled
genes (CCGs) responsible for clock output, as well as transactivate
the transcriptional repressor genes period and cryptochrome, that
constitute the negative loop [5].
Recent evidence reveals that circadian rhythms and metabolism
are tightly intertwined physiological processes. The circadian clock
regulates glucose homeostasis at the levels of both SCN and
peripheral clocks. Daily rhythms are observed in blood glucose
levels, glucose tolerance, insulin sensitivity and glucose uptake by
the brain, skeletal muscle and adipose tissue [7–9]. Moreover,
disturbances in the circadian rhythmicity and sleep-wake cycle in
humans, such as in shift-work personnel, are associated with
diabetes, metabolic syndrome, hypoleptinemia, increased appetite
and obesity [7]. Furthermore genetic disruption of several
canonical clock genes in animal models results in diverse and
profound metabolic disturbances, demonstrating the involvement
of clock genes in glucose homeostasis [7].
Our previous studies have demonstrated that ID2 has roles in
core clock function by interacting with CLOCK and BMAL1
through their HLH domain and inhibiting their transactivation
potential [4,10]. ID2 contributes to the input pathway of the
circadian system as demonstrated by the abnormally rapid
photoentrainment and increase in the magnitude of light-induced
phase shifts exhibited by Id2 null (Id22/2) mice [4]. In addition, a
role for ID2 in the output pathways of the circadian clock is
suggested by altered expression profiles of CCGs in the liver of
Id22/2 mice, including those involved in lipid metabolism [11].
Moreover, absence of Id2 results in impaired adipogenesis in vitro
[12] and reduced gonadal white adipose deposits and lipid content
in liver in adult mice [11]. Due to these findings, the entwined
nature of lipid and glucose metabolism and the interlocked
relationship of the molecular circadian clock with metabolic
processes [5], we hypothesized that ID2 contributes to the
regulation of glucose homeostasis, energy utilization and the
temporal regulation of feeding. It is well known that risk,
development and manifestation of obesity, metabolic syndrome
and insulin-resistance are sexually dimorphic, and animal models
suggest contributing roles of both gonadal hormones and sex
chromosomes [13–16]. Moreover, the effect of aging on the
circadian clock and on glucose homeostasis has been reported in
humans and animal models [17–20]. In the present study, our
objective was to characterize key aspects of metabolic function and
circadian regulation of activity and feeding in Id22/2 mice, and
furthermore, to examine this in a sex- and age-specific context. We
report here that Id22/2 mice have altered 24-hr patterns of
locomotor and feeding behavior, and reduced weight gain despite
elevated food intake, as well as sex-specific disturbances to
adipocyte programing and to lipid accumulation in skeletal muscle
and brown adipose tissue. We also report sex- and age-specific
changes in glucose homeostasis, including fasting hypoglycemia,
and increases in glucose tolerance, insulin sensitivity and glucose
uptake that are most prominent in male animals.
Results
Id22/2 Mice Show Altered Daily and Circadian Patterns
of Feeding and Locomotor Activity
Given that Id22/2 mice show altered circadian expression
patterns in the liver of genes involved in metabolism [11], the daily
[observed under light:dark (LD) cycle conditions] and circadian
[observed under constant darkness (DD)] patterns of feeding and
locomotor activity of Id22/2 mice were evaluated for possible
alterations. When the mean values of the daily counts of feeding
activity were analyzed, no significant difference was observed
between genotypes (Fig. 1A). However, Id22/2 mice were found
to be less active as demonstrated by the daily counts of general
activity determined by passive infrared (PIR) motion detectors
(Fig. 1B), and the wheel running activity (Fig. 1C), where Id22/2
mice exhibit significantly less activity compared to their wild type
(WT) littermates. Interestingly, WT females showed higher general
activity and wheel running activity compared to their male
littermates (Fig. 1B, Fig. 1C). To account for these genotype- and
sex-based differences in further analysis, the data for the daily and
circadian activity patterns were normalized to percentages of
average maximum activity.
Id22/2 mice displayed extended daily feeding activity towards
the late dark/night phase (ZT20 - ZT22) compared to their WT
littermates (Fig. 2A). This pattern persisted in DD with the activity
extending into the late subjective night (CT21 - CT0) (Fig. 2B).
Consistent with the feeding activity patterns, the daily and
circadian patterns of general movement were also altered in
Id22/2 when compared to WT mice, where Id22/2 nocturnal
activity persisted longer into the late dark phase (Fig. 2C, Fig. 2D).
Even though Id22/2 mice displayed a profound reduction in
wheel running activity, their daily and circadian wheel running
profile extended towards the late dark phase (Fig. 2E, Fig. 2F).
When the feeding and locomotor activity patterns under LD
conditions were examined according to sex, we observed that
Id22/2 females showed a more pronounced extended feeding
and locomotor activity profile than Id22/2males. The alterations
among Id22/2 males and females were more consistent under
DD conditions (Results S1, Fig. S1). Under LD conditions, we also
observed a difference between genotypes in the level of activity
during the light phase immediately prior to lights off (ZT12): a
level of anticipatory activity was observed in the WTs 0–3 hrs
before ZT12, a feature found reduced or absent in Id22/2 mice
(Fig. 2, Fig. S1).
Male Id22/2 Mice Show Less Body Mass Gain with
Greater Food Intake
Id22/2 mice have been reported to show reduced body weight
[4,12]. In the current study, we observed this in a sex-specific
manner between only male Id22/2 and WT mice (Fig. 3A). To
assess whether there was any difference in the pattern of weight
gain between WT and Id22/2 mice, we examined change in
body mass in cages provided with a running wheel or in standard
cages. In wheel cages Id22/2 males exhibited a significant weight
loss compared to a gain observed in WT males. A similar pattern
was observed between Id22/2 and WT females, although it was
less pronounced and did not reach statistical significance (Fig. 3B).
In standard cages, weight gain was not significantly different
between genotypes and sexes (Fig. S2A). In wheel cages, Id22/2
males consumed more food and Id22/2 females consumed less
food relative to body mass, when compared to WTs (Fig. 3C). The
food intake in standard cages showed similar results, except that
the difference between WT and Id22/2 females was not observed
to be significant (Fig. S2B). We also examined the food intake
during the light and dark phases of the LD cycle, and the
differences in food consumption among genotypes and sexes were
consistently observed in the dark phase (Results S1, Fig. S2C–F).
Female Id22/2 Mice Show Differential White Adipocyte
Size
Our earlier report revealed that Id22/2 mice have less gonadal
adipose deposits [11] (see also Fig. S6B). Histological evaluation of
gonadal WAT revealed that the adipocyte size was comparable
Id2 Null Mouse Circadian and Metabolic Phenotype
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between genotypes for males, but that female Id22/2 cells were
significantly smaller than female WT cells (Fig. 4).
Glucose Tolerance and Insulin Sensitivity are Enhanced in
Male Id22/2 Mice
Following on from the observation of differences in the feeding
pattern, food consumption and weight gain in Id22/2 mice, we
wished to examine whether Id22/2 mice showed changes in
glucose homeostasis. As age and sex are reported to influence
insulin sensitivity [21], we compared glucose tolerance, insulin
sensitivity and glucose-stimulated insulin secretion from both
‘young’ (2–5 months) and ‘old’ (10–22 months) groups of mice of
both sexes. Our results revealed that the fasting blood glucose
levels in the Id22/2 mice were significantly lower than age-
matched WTs, and for both Id22/2 and WT mice, the fasting
glucose levels decreased with age (Fig. 5A). Furthermore, fasting
plasma insulin concentrations were found to be significantly higher
in WT mice, which was further increased in older mice, whereas in
Id22/2 mice fasting plasma insulin remained low even in older
mice (Fig. 5B).
In both young and old mice a profound difference was observed
between genotypes in responses to i.p. glucose tolerance testing
(Fig. 6A, B). Male Id22/2 mice showed greater glucose tolerance
when compared to age-matched WT males. In an i.p. insulin
sensitivity test, young Id22/2 male mice displayed an enhance-
ment in insulin sensitivity compared to WT young males, which
was more pronounced in older Id22/2 males (Fig. 6C and 6D)
and sometimes resulted in hypoglycemic-induced catatonic
responses. Since we had observed a difference in the glucose
tolerance and insulin sensitivity, we further examined plasma
insulin concentrations after i.p. glucose injection in fasted male
mice. Our data revealed reduced insulin release in young Id22/2
males in fasting insulin values and at all times after glucose
injection, including at 2 min, when compared to WTs (Fig. 6E).
Older Id22/2 males also showed a difference in the fasting
insulin values when compared to WT males (Fig. 6F), but
following glucose injection, maintained levels comparable between
genotypes. Furthermore, in a separate set of measurements we
found that the 2 min insulin values of older Id22/2 males were
not significantly different from older WT males (t(10) = 1.6,
P = 0.148), although the mean value for WT males was 3.1-fold
higher than Id22/2 males (Fig. S3A).
No significant difference in glucose tolerance was observed
between Id22/2 and WT female mice either in the young
(Fig. 7A) or old groups (Fig. 7B). No significant effect of aging was
observed in the glucose tolerance of either WT or Id22/2
females. Also, the response to an i.p. insulin sensitivity test was not
different between genotypes in young females (Fig. 7C). Older
Id22/2 females did not exhibit an enhancement in insulin
sensitivity with respect to the overall response when compared to
WTs (Fig. 7D). We observed a significant enhancing effect of age
on insulin sensitivity that was comparable between WT and Id22/
2 females (Fig. 7C,D). Consistent with the insulin sensitivity and
glucose tolerance tests, glucose-stimulated insulin secretion in
young Id22/2 females was also not found to be different from
their WT littermates (Fig. 7E). Older Id22/2 females did not
show any significant difference in their glucose-stimulated insulin
secretion although they exhibited reduced basal insulin levels
compared to older WT females (Fig. 7F). Also, in a separate set of
experiments we found that the 2 min insulin levels of old Id22/2
females were not significantly different from WT females
(t(11) = 1.5, P= 0.167); however, the mean level of WT females
was 1.6-fold higher than Id22/2 females (Fig. S3B).
Glucose Uptake is Elevated in the Skeletal Muscle and
Interscapular Brown Adipose Tissue of Male Id22/2 Mice
Since Id22/2 mice showed greater insulin sensitivity, we
evaluated glucose uptake in different tissues with known insulin
responsiveness using MicroPET imaging (Fig. 8A). Quantification
of FDG uptake (as standard uptake value [SUV] and determined
from mean voxel values) by brain and heart revealed no significant
difference in their respective SUVs between genotypes or sexes
(Fig. S4A, S4B). However, FDG uptake by forelimb skeletal
muscle was higher in Id22/2 males when compared to WT
males, and was especially higher than that of Id22/2 females
(Fig. 8B). When represented as SUV from maximum voxel value,
this difference in FDG uptake by the skeletal muscle of Id22/2
males was found to be more pronounced (Fig. S4C). Interestingly,
the SUV of WT skeletal muscle displayed a positive correlation
with body mass and age (Spearman’s rank order correlation:
R= 0.682, p,0.05; R= 0.712, p,0.05; n = 11). A remarkable
enhancement of iBAT activity was observed in Id22/2 mice
(Fig. 8C). Quantitation of FDG uptake in iBAT revealed a higher
SUV for Id22/2 males compared to WT males (Fig. 8D). To
eliminate the possible effect of a generally smaller body mass in
Id22/2 males, we compared the FDG uptake between mass-
matched male mice and found that the average SUV was 1.8-fold
higher in Id22/2 males (body mass = 24.5g, SUV=3.0 mg/ml)
than WT males (body mass = 24.060.42g, SUV=1.6660.75 mg/
ml, mean 6 SEM). In addition, no correlation was observed
Figure 1. Id22/2 mice exhibit less locomotor activity compared to WT mice. A) Daily feeding activity counts of Id22/2 and WT mice
(ANOVA: genotype, n.s.; sex, n.s.; interaction, n.s). B) Daily general activity counts in Id22/2 and WT mice determined by passive infrared motion
detectors (genotype, P,0.05; sex, P = 0.057; interaction, n.s). C) Daily wheel revolution counts of WT and Id22/2 mice (genotype, P,0.001; sex,
P,0.05; interaction, P,0.01). Values represent mean 6 SEM. ***p,0.001.
doi:10.1371/journal.pone.0073064.g001
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between the SUV and the volume delineated for analysis, the body
mass or age, either in WT mice or in Id22/2 mice, unless
otherwise stated. Also, genotypic and sex differences in body mass
were consistent with subjects used in the food intake/weight gain
analysis (Fig. S4D).
The volume of activated iBAT was higher in Id22/2 mice of
both sexes compared to WTs, indicating an elevated total FDG
uptake by iBAT, irrespective of the mean SUVs (Fig. 8E).
Furthermore, females showed greater activated iBAT volume than
males in both genotypes (Fig. 8E). We also observed a negative
correlation between body mass and activated iBAT volume in WT
mice (Spearman’s rank order correlation: R=20.745, P,0.01,
n = 11) (Fig. 8F). This correlation was not observed in Id22/2
mice (R=20.259, P= 0.402, n= 12), probably owing to their
smaller body mass. No correlation was observed between the
delineated activated volume and SUV of iBAT, either in WT mice
or in Id22/2 mice, eliminating the possibility of any positive
effect of high FDG uptake in the activated volume determination.
We evaluated the mass of iBAT from older mice and found that
WT males had a greater iBAT weight (Fig. S5A). This suggested
that the activated iBAT volume we have observed does not
correspond to the amount of iBAT present, but the spread of its
FDG uptake. The iBAT mass was found to increase with body
mass in both WT and Id22/2 mice (Spearman’s rank order
correlation: WT, R=0.922, P,0.001, n= 15; Id22/2,
R= 0.898, P,0.001, n= 8). Consistent with the lean phenotype
for Id22/2 mice, Oil Red O staining of iBAT from older mice
Figure 2. Id22/2mice show altered daily and circadian patterns of feeding and locomotor activity. A) Daily feeding activity profile of WT
and Id22/2 mice (ANOVA: time (T), P,0.001; genotype (G), n.s.; interaction (I), P,0.01). B) Circadian feeding activity profile of WT and Id22/2 mice
(T, P,0.001; G, n.s.; I, P,0.05). C) Daily PIR motion detector general activity profile of WT and Id22/2 mice (T, P,0.001; G, P,0.05; I, P,0.001). D)
Circadian general activity profile of WT and Id22/2mice (T, P,0.001; G, P = 0.15; I, P,0.001). E) Daily wheel running activity profile of WT and Id22/2
mice (T, P,0.001; G, P,0.001; I, P,0.001). F) Circadian wheel running activity profile of WT and Id22/2mice (T, P,0.001; G, P,0.01; I, P,0.001). The
shaded area in the plots represents dark phase of the LD cycle or constant darkness. Values shown represent mean 6 SEM. *p,0.05, **p,0.01 and
***p,0.001.
doi:10.1371/journal.pone.0073064.g002
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revealed greater lipid deposition in WT males compared to Id22/
2 males (Fig. S5B, S5C).
Skeletal Muscle Triglyceride (TG) and Total Diacylglycerol
(DAG) are Lower in Male Id22/2 Mice, and Proportions
of Specific DAG Species are Altered
Intramyocellular DAG accumulation has been associated with
insulin resistance, as DAG modulates intracellular insulin signaling
and action, thereby decreasing insulin sensitivity [22]. We
therefore analyzed the TG and DAG content of forelimb skeletal
muscle to better understand the enhanced skeletal muscle glucose
uptake and increased insulin sensitivity in the male Id22/2 mice.
We observed a significant sex-specific difference between mice for
both TG and total DAG content, and post hoc tests revealed a
lower content in male Id22/2 mice as compared to female Id22/
2 mice. (Fig. 9A, 9B). A detailed analysis of each specific DAG
species revealed differences between sexes, but in particular
between male Id22/2 and WT mice. For instance, in Id22/2
males DAG species containing the fatty acyl groups palmitoyl-
oleoyl and oleoyl-oleoyl were reduced, and stearoyl-stearoyl,
linoleoyl-stearoyl, oleoyl-stearoyl and stearoyl-palmitoyl were
elevated (Fig. 9C).
Discussion
ID2 is a HLH transcriptional repressor, rhythmically expressed
in many mammalian tissues and previously reported to be involved
in the input pathways, core clock function and output pathways of
the circadian clock, and in adipogenesis [4,10–12]. In the present
study we have characterized an altered circadian rhythm and
metabolic phenotype in Id22/2 mice, revealing a role for ID2 in
the circadian regulation of feeding and locomotor behavior and in
glucose metabolism.
Our studies show that Id22/2 mice exhibit lower levels of
locomotor activity, and have extended activity patterns of feeding
and locomotor activity. We also observed that WT females showed
higher general activity and wheel running activity compared to
WT males, a finding consistent with the reported sexual
dimorphism in locomotor activity levels for various mouse strains,
including C57BL/6J and 129x1/SvJ [23]. We also observed in
Id22/2 mice a reduced level or absence of anticipatory activity
0–3 hr prior to the time lights off (ZT12). This finding is consistent
with our earlier report in which Id22/2 mice were observed to
have a significant ,30 min delay in the phase angle of activity
onset relative to WTs [4]. In WT mice the period of high activity is
relatively short, peaking during the early dark/night phase of the
LD cycle, in comparison with the longer and sustained profiles of
Figure 3. Resistance to weight gain in Id22/2mice. A) Body weight comparison between WT and Id22/2mice (ANOVA: genotype (G), P,0.05;
sex (S), P,0.01; interaction (I), P,0.05). B) Weekly weight gain pattern of Id22/2 and WT mice in cages equipped with a running wheel (G, P,0.01; S,
n.s.; I, n.s.). C) Daily food intake of Id22/2 and WT mice in wheel cages (ANOVA: G, P,0.01; S, n.s.; I, n.s). Values shown represent mean 6 SEM.
*p,0.05, **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0073064.g003
Figure 4. Cell size of the gonadal white adipose tissue is different between female Id22/2 and WT mice. A) Representative images of
hematoxylin/eosin stained gonadal white adipose tissue sections of male and female WT and Id22/2mice (scale bar = 50 mm). B) Cell area of gonadal
WAT in WT and Id22/2 mice (ANOVA: genotype, P,0.05; sex, n.s.; interaction, P,0.001). No significant correlation was detected between cell size
and age of animal (Spearman’s rank order correlation/linear regression, n.s.).
doi:10.1371/journal.pone.0073064.g004
Id2 Null Mouse Circadian and Metabolic Phenotype
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Figure 5. Fasting glucose and Insulin levels while aging. A) Fasting blood glucose levels of young and old, WT and Id22/2 mice (ANOVA:
genotype, P,0.01; age, P,0.001; interaction, n.s.). B). Fasting insulin levels of young and old, WT and Id22/2mice (genotype, P,0.001; age, P,0.05;
interaction, n.s.). Values shown represent mean 6 SEM. *p,0.05, **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0073064.g005
Figure 6. Id22/2male mice display enhanced glucose tolerance and insulin sensitivity. A) Glucose tolerance test (GTT) of young male WT
and Id22/2 mice (RM-ANOVA: time (T), P,0.001; Genotype (G), P,0.05; interaction (I), n.s). B) GTT of old male WT and Id22/2 mice (T, P,0.001; G,
P,0.05; I, P = 0.001). C) Insulin tolerance test (ITT) of young male WT and Id22/2mice (T, P,0.001; G, P,0.05; I, n.s.). D) ITT of old male WT and Id22/
2 mice (T, P,0.001; G, P,0.01; I, P,0.001). E) Glucose-stimulated insulin release in young male WT and Id22/2mice (T, P,0.01; G, P,0.01; I, n.s.). F)
Glucose-stimulated insulin release in old male WT and Id22/2 mice (T, P = 0.103; G, P,0.01; I, n.s.). No effect of aging was observed in the glucose
tolerance of either WT or Id22/2 males (RM-ANOVAs, n.s.). Comparison on young and old Id22/2 males reveal an increase in insulin sensitivity (T,
P,0.001; A, P,0.001; I, P,0.01) in the older group. This large age effect was not observed in WTs (T, P,0.001; age (A), p = 0.06; I, P,0.05), although
there was tendency for a slower recovery to baseline glucose levels at 90 and 120 mins (p,0.05). Values shown represent mean 6 SEM. *p,0.05,
**p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0073064.g006
Id2 Null Mouse Circadian and Metabolic Phenotype
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Id22/2 mice, spanning early to late dark/night phase. That
Id22/2 mice exhibit prolonged activity patterns of feeding and
locomotor activity not only under LD but also DD conditions
demonstrates the presence of an altered biological clock in Id2
mutants.
There are several possible mechanisms that could explain the
altered locomotor and feeding rhythms in Id22/2 mice. Given
that ID2 plays a role in regulating circadian clock output in the
liver, including metabolic CCGs, and because Id2 is ubiquitously
expressed and rhythmic [3,4,11], it is plausible that such a pivotal
role is a feature of clocks throughout the body. This would include
the hypothalamic brain and peripheral tissues involved in
metabolic homeostasis.
Animals undergo vast changes in physiology to maintain
metabolic homeostasis during the normal daily 24 hr feeding-
fasting cycles and cycles of physical activity and arousal [5,24].
Lack of precise time-of-day specific phase coordination between
rhythmic processes within and between the metabolic organ
systems (i.e. SCN, hypothalamic feeding-fasting centers, liver,
WAT, BAT, skeletal muscle, pancreas, intestine), including
impaired nutrient signaling (e.g. leptin, orexin, ghrelin), would
predictably result in disruption of the normal balance of energy
storage and utilization [5,24]. Such disruption is thought to
underlie the hyperphagic/obese phenotype of the clock mutant
mouse [25]. It is noteworthy that ID2 can interact with CLOCK
and its partner protein BMAL1 and modify both their localization
signal and transactivation potential [10]. This general or perhaps
tissue-specific disturbance in clock control may underlie both the
behavioral and also physiological features (i.e. enhanced glucose
uptake/reduced lipid storage) of the Id22/2 phenotype. We
therefore suggest that the altered state of feeding and locomotor
activity behaviors coupled with reduced physical activity, are a
response to or the direct result of disruption in circadian metabolic
homeostasis. These changes that we report in behavior would
result in reduced energy expenditure and provide for a more
sustained nutrient intake during the night. The most likely site for
Figure 7. Glucose tolerance, insulin sensitivity and insulin release in Id22/2 females is unaltered. A) GTT of young female Id22/2 and
WT mice (RM-ANOVA: time (T), P,0.001; genotype (G), n.s.; interaction (I), n.s.). B) GTT of old female Id22/2 and WT mice (T, P,0.001; G, n.s.; I, n.s.).
C) ITT of young female Id22/2 and WT mice (T, P,0.001; genotype, n.s.; I, n.s.). D) ITT of old female Id22/2 and WT mice (T, P,0.001; G, P,0.01; I,
n.s.). E) Glucose-stimulated insulin release in young female Id22/2 and WT mice (T, P,0.001; G, n.s.; I, n.s.). F) Glucose-stimulated insulin release in old
female Id22/2 and WT mice (T, n.s.; G, P = 0.055; I, n.s.). No effect of aging was observed in the glucose tolerance of either WT or Id22/2 females
(RM-ANOVAs, n.s.). An aging effect of insulin sensitivity was observed for WT and Id22/2 females (T, P,0.001; age, P,0.001; I P,0.001). Values
shown represent mean 6 SEM. **p,0.01.
doi:10.1371/journal.pone.0073064.g007
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these changes in behavior is the SCN and hypothalamic feeding-
fasting centers, known to regulate rhythmicity, wakefulness and
feeding [5,24]. Another possibility is that the behavioral changes
reflect a disruption of normal SCN clock/output function
[4,10,11], rather than a response to a system-wide metabolic
alteration. Finally, reduced adipogenesis in the Id22/2 mouse
[12] would likely compound any circadian disruption by reducing
the lipid storage capacity of the animal. However, it is not
sufficiently clear to what extent these processes can be considered
distinct.
Our data revealed that Id22/2 males had a lower body weight
while counter intuitively consuming greater relative quantities of
food and simultaneously gaining less weight compared to WT
males. This difference in body weight and weight gain was not
observed in females. This observation could be explained in part
by earlier findings of impaired adipogenesis and reduced adiposity
in Id22/2 mice [11,12]; and possibly by increased energy
expenditure in BAT and skeletal muscle, as suggested by elevated
FDG uptake specifically in Id22/2 males. This could also partly
be attributed to the sex difference in the weight gain of WT mice,
observed in C57Bl/6J mice, where males are more susceptible to
obesity, and this advantage of females is abolished by ovariectomy
[26]. Our results show that ablation of Id2 reduces body mass gain
in male mice. In fact there was a reduction in body mass in male
Id22/2 mice in contrast to an increase observed in WT males.
This weight loss was only detected in the presence of a running
wheel, even though Id22/2mice do not run in the wheel as much
as WTs. The wheel could act as an enriched environmental
Figure 8. Id22/2 mice display elevated FDG uptake and activated volume of interscapular brown adipose tissue (iBAT). A) Shows a
representative PET acquired image of FDG uptake in sagittal plane highlighting iBAT (dorsal) with high uptake. The injection site (right eye) and
bladder are also visible. B) Quantitative analysis of FDG uptake in forelimb skeletal muscle in WT and Id22/2 mice represented as SUV (ANOVA:
genotype (G), P = 0.152; sex (S), P,0.05; interaction (I), P = 0.108). C) Micro PET images of FDG uptake in iBAT at transverse (top) and coronal (bottom)
planes for WT and mice. D) Quantitative analysis of the iBAT FDG uptake in WT and Id22/2 mice represented as standard uptake value (SUV) (G,
P,0.01; S, n.s.; I, n.s.). E) Activated iBAT volumes obtained from micro PET studies of WT and Id22/2mice (G, P,0.001; S, P,0.001; I, n.s.). F) Activated
iBAT volumes of WT mice show a negative correlation with the body mass, which was not observed in the Id22/2 mice. Values shown represent
mean 6 SEM. *p,0.05 and **p,0.01.
doi:10.1371/journal.pone.0073064.g008
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stimulus to which the Id22/2 mice might show a greater
response, since an enriched environment can improve metabolic
health through increasing adaptive thermogenesis and browning
of white adipocytes and thus increasing energy dissipation [27].
Earlier studies from our laboratory and others have shown that
Id22/2 mice have less gonadal white adipose deposits [11,12].
The present histological data show no significant difference in the
gonadal adipocyte cell size between male WT and Id22/2 mice,
suggesting that the reduced adiposity observed in male Id22/2
mice is due to a lower number of adipocytes. However, we did
identify a sex-specific difference in which cells were smaller in
female Id22/2 mice relative to female WT controls. Thus,
reduced adiposity observed in female Id22/2 mice might be the
result of a different mechanism, in which adipocyte number does
not change but lipid accumulation does. Interestingly, the
difference observed between female Id22/2 and WTs is
consistent with reports of smaller adipocytes in Id12/2 and
Id42/2 mice [28,29]. However, in these studies either no clear
indication of animal sex was provided or no differentiation of sexes
reported. Clearly this underlies yet another sex-specific feature of
the Id2 null phenotype, that of differential adipocyte programing.
These results could be attributed to the impaired adipocyte
differentiation in the absence of Id2. It has also been observed that
Id2 promotes PPARc expression, morphological differentiation
and lipid accumulation during adipogenesis [12]. Id2 gene
expression is elevated in the initial phase of adipocyte differenti-
ation and dramatically drops in the later phase [30,31]. Here, ID2
potentially acts as a differentiation-inducing factor, as ID proteins
are suggested to inhibit premature differentiation of progenitor
cells and regulate cell fate determination [2]. A similar expression
pattern has been observed for C/EBPb, a key adipocyte
differentiation inducer [32], which induces Id2 expression during
this process [33]. Interestingly, C/EBPb null mice also exhibit
reduced epididymal WAT deposits, impaired adipocyte differen-
tiation and reduced lipid accumulation in BAT [34]. Moreover,
specific clock genes contribute to adipogenesis, including BMAL1,
which acts as negative regulator of adipogenesis [35,36]. Since
previous studies in our laboratory have indicated that ID2 can
interact with BMAL1 and reduce its transactivation potential
Figure 9. Skeletal muscle triglyceride (TG) and diacylglycerol (DAG) profiles in Id22/2 mice. A) Total TG content of tibialis anterior
muscle (ANOVA: genotype (G), n.s.; sex (S), P,0.05; interaction (I), n.s.). B) Total DAG content of tibialis anterior muscle (G, n.s.; S, P,0.01; I, n.s.). C)
DAG species analysis. DAG species are abbreviated as two contributing fatty acyl groups: A, E, S, O, L and P denote arachidonoyl, eicosapentanoyl,
stearoyl, oleoyl, linoleoyl and palmitoyl groups, respectively. Values represent mean 6 SEM. *p,0.05, **p,0.01 and ***p,0.001 are Turkey post-hoc
tests following two way ANOVA for TG, DAG or each DAG species.
doi:10.1371/journal.pone.0073064.g009
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[4,10], it raises the possibility that ID2 might positivity regulate
adipogenesis via inhibition of BMAL1 activity.
Male Id22/2 mice displayed enhanced glucose tolerance,
greater insulin sensitivity, low basal insulin levels and lower levels
of glucose-stimulated insulin secretion when compared to WTs.
Furthermore, glucose tolerance and insulin sensitivity were even
more pronounced in aged male Id22/2 mice. Our results
revealed that the fasting blood glucose levels in the Id22/2 mice
were significantly lower than age-matched WTs, and for both
Id22/2 and WT mice, the fasting glucose levels decreased with
age. It is conceivable that this difference between young and old
animals, irrespective of genotype, is a result of habituation to
handling occurring in older animals [37]. However, there still
remains a large reduction in fasting glucose in Id22/2 animals at
each age-matched group. Furthermore, these collective glucose
homeostasis tests, including basal and glucose-stimulated insulin
levels, demonstrate that the ability of male Id22/2 mice to
improve glucose tolerance is not associated with enhanced
circulating insulin levels. In fact, surprisingly, in the young male
Id22/2 mice, significantly less insulin is produced, thereby
revealing a dramatically enhanced insulin sensitivity despite
reduced insulin concentrations.
The enhanced glucose uptake by skeletal muscle and BAT of
the male Id22/2 mice could contribute to the elevation in insulin
sensitivity. Consistent with the weight gain pattern, female mice
did not show any significant differences in the glucose homeostasis
parameters when compared to WTs, apart from the lower basal
insulin levels in the older group. Moreover the positive effect of
aging on insulin sensitivity was observed in females irrespective of
genotype. Our findings suggest the role of sex and age in the
development of enhanced insulin sensitivity in the absence of ID2.
This is consistent with the report that females are less susceptible to
develop insulin resistance associated with diet-induced obesity, and
where ovarian hormones are implicated [16].
An evaluation of glucose uptake by FDG-MicoPET imaging
revealed higher FDG levels in the skeletal muscle of Id22/2
males. Considering the total mass of skeletal muscle in the body, a
small difference in glucose uptake in the forelimb muscle could be
indicative of a highly elevated glucose uptake by total skeletal
muscle in Id22/2 males. Furthermore, insulin resistance in
skeletal muscle is associated with aging [20,38,39], and sexual
dimorphism is observed in the development of insulin resistance
[40,41]. Since Id2 expression in the skeletal muscle is reported to
increase during aging [42], it is possible that the difference
between Id22/2 and WT males in skeletal muscle glucose uptake
also increases with age. The fact that Id2 is up-regulated in the
skeletal muscle of obese type II diabetic mice further suggests a
role of Id2 in the development of skeletal muscle insulin resistance
[43].
Accumulation of intramyocellular TG and especially DAG are
associated with insulin resistance [22]. We found that the
concentrations of these lipids were significantly reduced in the
skeletal muscle of Id22/2 males as compared to Id22/2 females:
67% lower for TG, and 25% for total DAG. These data in part
could explain both the enhanced insulin response and elevated
skeletal muscle glucose uptake observed in the Id22/2 male but
not female animals, through altered insulin signaling. Further-
more, the differences in the distribution of individual DAG species,
observed between males and females (sex-specific differences), and
especially between male Id22/2 versus male WT mice, reveal the
complexity of the Id22/2 phenotype in terms of fatty acid
composition. Interestingly, amongst several differences, the DAG
species distribution data also indicate an elevated availability/
metabolism of stearate (C18:0) in the Id22/2 male compared to
WT male controls. It has been suggested that alterations in specific
DAG species may differentially contribute to insulin resistance
[44], and so these disturbances in DAG distribution in the Id22/
2 males could contribute to the increased glucose uptake by
altering insulin signaling [11].
While the total DAG findings do not fully explain the genotypic
differences we observed at the physiological level, they might in
part constitute an explanation for the sex-specific element
contributing to the glucose uptake and insulin sensitivity pheno-
type seen only in male Id22/2 mice. Likewise, these reductions in
intramuscular TG/DAG may reflect reduced circulating lipids
and/or increased myocyte mitochondrial fatty acid oxidation, as
might be predicted from increased insulin sensitivity [44].
However, it still remains plausible that because of the intra-sex
differences observed in DAG species composition between male
Id22/2 and male WT mice, DAG might contribute to the
genotypic differences. At the very least, low total DAG would be
permissive to additional genotypic changes that are enhancing
insulin sensitivity [42,43].
We have observed that the average FDG uptake by iBAT is
elevated in Id22/2 male mice. In addition, our data revealed a
higher activated iBAT volume for Id22/2 mice of both sexes as
well as the females of both genotypes. This is consistent with
observations in adult humans, where females show increased mass
of active iBAT [45]. However, since the actual mass of iBAT was
lower in Id22/2 males and WT females than WT males, it is
plausible that this elevated activated iBAT volume might also
include recruitable brown adipocytes/beige adipocytes localized in
the surrounding WAT mass [27,46]. We also observed that the
activated iBAT volume decreased with increase in body mass in
WT mice, but not in Id22/2 mice. Similar observations were
reported in humans, where an increase in body mass index (BMI)
reduces the chance of detecting active BAT [45]; and BAT
activity, measured as total FDG uptake, is negatively correlated
with BMI and body fat percentage [47]. Our data from older mice
revealed that WT male iBAT acquire greater weight and lipid
deposits than Id22/2 males and WT females. We speculate that
the presence of higher levels of lipid depositions in WT male iBAT
might make it larger in size and less metabolically active per unit
volume. In the Id22/2 male iBAT, higher glucose uptake,
indicative of increased metabolic activity, suggests a higher
thermogenic activity.
The situation in the Id22/2 male is indicative of the system-
wide reduction in lipid accumulation, i.e. in addition to reduced
quantities of WAT, this group has the lowest levels of skeletal
muscle TG and DAG, and has low BAT lipids relative to WT
males. Being that male Id22/2 mice on average have a smaller
body mass, the changes in BAT physiology may be an adaptive
response to an unfavorable surface area to mass ratio and
compensating for increased loss of body heat [48]. It is plausible
that to compensate for the increased energy expenditure, the mice
increase food intake and reduce their locomotor activity. However,
in the small cohort of body mass-matched male animals, male
Id22/2 FDG uptake was still found to be elevated in respect to
male WTs, suggesting that this tangible factor would not explain
the entire extent of the BAT phenotype. Furthermore, in females,
where there is no difference in body mass between mutant and
WT animals, there still remains an elevation in activated BAT
volume. In the Id22/2 females this increase in activated BAT
volume also suggests a level increase in metabolic/thermogenic
activity. Again, the observed reduction in activity might compen-
sate for this increase energy expenditure.
Another mechanistic explanation for the observations in Id22/
2 BAT and skeletal muscle and in glucose homeostasis would be
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associated with the circadian clock. As there are endogenous clock
mechanisms within BAT, WAT and skeletal muscle [3,8,49,50],
the Id2 null phenotype might be as a result of disturbances to their
normal intrinsic temporal coordination of CCGs and subsequent
metabolic process [49,50]. As $7% of genes are rhythmically
regulated in these tissues, including Id2 [3,49,51,52], and as Id2 is
implicated in regulating clock output [11], it is plausible that the
absence of ID2 would result in a subset of CCGs being abnormally
regulated, with potential consequences to local and systemic
physiology.
Similar to the metabolic phenotype in Id22/2 mice, enhanced
insulin sensitivity and increased glucose uptake by WAT and BAT
were observed in a non-obese type 2 diabetic mice model in
response to b3-adrenergic receptor activation [53]. Of note, b-
adrenergic signaling induces PGC-1a, a thermogenic gene
suggested to link the circadian clock and metabolism [54], and
mice null for PGC-1a in WAT develop insulin resistance [55].
Interestingly, PGC-1a expression is elevated in Id22/2 liver [11].
In addition to PGC-1a, altered gene expression of other
metabolic genes in Id22/2 liver could explain the present
observations on Id22/2 mice. The rhythmically expressed genes
Igfbp1 and Igfbp2, encoding insulin like growth factor (IGF) binding
proteins, are up-regulated in Id22/2 liver [11]; in the case of
Igfbp1, a change in the peak phase of its rhythmic profile is
observed. IGFBPs are predominantly inhibitory to IGF action,
and IGFBP1 can inhibit IGF1-mediated differentiation of
preadipocytes [56]. IGFBP2 can inhibit adipocyte differentiation
in vitro, and when overexpressed in vivo, mice are protected from
developing age- and diet-induced obesity and insulin resistance
[57]. Fibroblast growth factor (FGF) receptor 1 is also up-regulated in
Id22/2 liver [11], interesting given that FGFs, including FGF21,
are regulators of glucose and lipid metabolism [58].
In contrast to the metabolic phenotype observed in the absence
of Id2, elevated expression of Id2 is associated with obesity and/or
diabetes. Id2 expression in adipocytes is positively associated with
obesity in mice and humans [12]. The Id2 gene promoter contains
a conserved CREB binding site, and its expression is stimulated in
adipocytes by cAMP or a high fat diet [31,59]. Also CREB is
activated in adipocytes of obese mice where it promotes insulin
resistance [59]. Increased Id2 expression is observed in the muscle
of obese type II diabetic mice and in the liver of type I diabetic
mice [43,60], and thiazolidinedione, a class of anti-diabetic drugs,
inhibits Id2 expression in human aortic smooth muscle cells [61].
Moreover glucose is reported to induce Id2 expression in
macrophages [62]. Taken together these findings clearly reveal
the involvement of ID2 in the regulation of glucose/lipid
metabolism and in the development of obesity and/or diabetes.
Similar to the Id22/2 mouse, a metabolic phenotype of
reduced fat mass, increased insulin sensitivity and enhanced
energy expenditure has been observed in Id1 null mice. In contrast
to ID2, ID1 is not required for adipocyte differentiation, and
adipocyte differentiation is in fact accelerated in Id12/2 cells
in vitro [29]. Defective adipogenesis is not implicated in the lower
adiposity of Id12/2 mice [29]. Even though basal insulin levels
are lower in Id12/2 mice, their glucose-stimulated insulin
secretion is highly elevated, enhancing their glucose tolerance
[63]. This is in contrast to the reduced levels of glucose-stimulated
insulin we observed in Id22/2 mice. However enhanced gene
expression of thermogenic proteins is also reported in Id12/2
mice [29], suggesting their BAT metabolic activity may be
elevated as observed in Id22/2 mice. Similar to Id2, Id4 is also
reported to be necessary for adipogenesis, and Id42/2 mice
exhibit reduced body weight and adipose deposits, including
smaller adipocytes [28]. Loss of Id3 does not affect weight gain or
adipose deposit size in regular chow fed mice, but does result in
reduced high fat diet induced visceral fat pad expansion [64].
Therefore the metabolic phenotypes observed in the absence of
different ID proteins may not be the result of similar mechanisms,
in spite of the possible functional redundancies amongst them.
Considering the involvement of ID2 in input pathways, core
clock function and output pathway of circadian clock and also in
adipogenesis [4,10–12], we propose possible mechanisms for the
development of the observed circadian and metabolic phenotypes
in Id22/2 mice. Ablation of Id2 could possibly alter the master
clock in the SCN, thereby altering feeding and locomotor activity
rhythms. Another possibility is an altered feeding pattern, either
because of the altered CCG expression in periphery, as seen in
liver [11], or centrally within the hypothalamic feeding centers
[6,24]; or because of a more persistent drive for feeding owing to
lower energy storage capabilities (i.e. lipids), at least in part, due to
reduced adipogenesis [48]. This would generate a drive for the
animal to be active for a longer duration and thus alter locomotor
activity rhythms. The lean phenotype in Id22/2 males could be a
result of increased glucose uptake and utilization in both skeletal
muscle and BAT, as well an increase in BAT thermogenesis.
Likewise, there may be a generalized increase in metabolic
activity, i.e. both glucose and fatty acid oxidation, as might be
predicted from the increased insulin sensitivity and elevated FDG
uptake. These changes in energy metabolism may reflect a
disturbance in circadian clock function, occurring specifically
within skeletal muscle and BAT [3,8,49,50] and beyond these
tissues, and thereby disrupting normal temporal coordination of
metabolic processes; or the changes in energy metabolism may be
a poor adaptation to the lower energy storage capabilities. The
changes in glucose uptake coincide with enhanced insulin
sensitivity and glucose tolerance in Id22/2 males. The sex-
specific lower intramuscular total DAG, as well as differential
profile of DAG species in male Id22/2 mice, might also
contribute to the increased insulin sensitivity and glucose uptake;
although a low concentration of intramuscular lipid in itself is a
reflection of the lean state, most pronounced in the male Id22/2
mouse. The lean phenotype in Id22/2 males might also
necessitate increased thermogenesis to compensate for a loss of
body heat. It is plausible that to compensate for the increased
energy expenditure, Id22/2 males increase food intake and
reduce their locomotor activity.
In conclusion, we find that Id22/2 mice exhibit altered feeding
and locomotor rhythms, fasting hypoglycemia, sex- and age-
dependent enhanced glucose tolerance and insulin sensitivity, and
sex-dependent elevated glucose uptake in skeletal muscle and
BAT. Our observations clearly suggest the role of the ubiquitously
expressed and rhythmic Id2 gene in regulating pathways involved
in glucose and lipid metabolism, as well as in the circadian control
of feeding and locomotor activity behavior. BAT has received
considerable attention recently as a potential therapeutic system to
combat obesity, especially after it was discovered to occur in adult
humans [65]. Our current data and earlier reports of Id2 up-
regulation during aging, suggests ID2 to be a potential therapeutic
target for treating metabolic and circadian disorders in adults.
Further, these data reinforce the relevance of sex and age-specific
analyses in studying models of metabolic and circadian function as
they pertain to human health and disease. In particular they also
help to improve understanding of the development of obesity and
diabetes, diseases prevalent in shift work personnel.
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Materials and Methods
Ethics Statement
Animal experiments were approved by the University of Notre
Dame Animal Care and Use Committee (protocol number 14–
080) and performed in accordance with NIH Guidelines for the
Care and Use of Laboratory Animals.
Animals
The generation of Id2 mutant mice and determination of
genotypes were performed as described previously [4]. Id2 WT
and Id22/2 mice were on a mixed background for breeding
purposes: 129sv/C57BL6J/FBVN [4] or 129sv/C57BL6J/
FBVN/CD1 for skeletal muscle lipid analysis. The latter mice
are lean, exhibit reduced gonadal WAT deposits, and males have a
lower body mass (Figure S6), consistent with the previous analysis
of Id22/2 mice [4,11] and current study groups (Fig. 3, Fig. S4).
Mice were provided with regular chow diet (Teklad Global diet
2919; kcal 2 22% from fat, 23% from protein and 55% from
carbohydrate) and sterile water containing antibiotic (sulfameth-
oxazole/trimethoprim oral suspension [Alpharma, Fort Lee, NJ]
at a final dilution of 400 and 80 mg/liter, respectively) ad libitum,
unless otherwise noted. The mice were entrained to a 12:12 light:
dark (LD) cycle with lights on at Zeitgeber time (ZT) 0 and lights
off at ZT 12, and at a temperature of 20u–21uC and 50–65%
humidity. In all experiments, Id2+/+ littermate animals were used
as WT controls.
Feeding and Locomotor Activity Recording
Mice (5–16 month old) were housed individually in 12:12 LD
cycle (light, 150–400 lux, fluorescent lights: General Electric 36-W
cool white; dark, 0 lux) or DD (constant darkness, 0 lux)
conditions. Feeding activity (visits to the hopper), passive infrared
(PIR) motion detector general movement activity (Slimline PIR
motion detector, Smarthome, Irvine, CA) and wheel running activity
were simultaneously recorded every min for 20–30 days using
specialized cages that were constructed in-house. Activity was
monitored by a personal computer and using Clocklab hardware
and software (Actimetrics, Wilmette, IL). Individual animal data of
each minute from 5 consecutive days within 10–21 days into the
experiment were selected for analysis of all three metrics. To
account for the genotype and sex differences in the amplitude of
activity (prominent in wheel running and PIR general activity),
data from each individual were averaged into hourly bins and
converted to percentage values, with the maximum values as
100% for each mouse. In DD conditions, the free running period
length of each individual mouse was determined from wheel
running activity or PIR activity, and data from this 5-day period
were fitted into a 24-hr scale. The time of activity onset was
determined by fitting lines to the actograms generated for 7–10
consecutive days in DD, either for wheel running activity or for
PIR physical activity, and this was set to circadian time 12 (CT
12).
Food Intake and Weight Gain Measurements
The mice (7–12 month old) were housed individually in cages
with or without running wheels, with free access to water and
regular chow. The day and night food consumption were
determined by manual measurement of food every 12 hrs at
ZT0 (lights on) and ZT12 (lights off) for at least 10 consecutive
days. The mice were weighed every 3 days and the weekly weight
gain was determined.
Glucose and Insulin Tolerance Tests and Analysis of
Insulin Release
For the glucose tolerance tests and the analysis of insulin release
in response to glucose, mice were fasted 16 hrs prior to a baseline
measurement of blood glucose or plasma insulin, eliminating the
possible effect of difference in the time of food intake on the
measurements. This was followed by intra-peritoneal injection of
D-glucose (1.5 g/kg of body mass) and subsequent blood glucose
measurements at 0, 10, 20, 30, 60, 90, and 120 min from a distal
tail vein bleed. All glucose measurements were made with a
handheld glucometer (One Touch Ultra, Milpitas, CA). Similarly
for plasma insulin measurements, a series of blood samples were
taken at 0, 2, 15, 30, and 45 min after the i.p. injection of glucose.
The plasma separated from them was used for determining the
insulin concentrations by ELISA (Crystal Chem, Inc., Downer’s
Grove, IL). For insulin tolerance test the mice were fasted for 2 hrs
and their baseline blood glucose levels were measured. This was
followed by an i.p. injection of 0.75 units/kg body mass insulin
(Humulin R, Eli Lilly and Co., Indianapolis, IN) and subsequent
blood glucose measurements at the same time points as for the
glucose tolerance test. All measurements were performed between
ZT4 and ZT8. Mice were tested in two age cohorts, 2–5 and 10–
22 months.
MicroPET Studies
Positron emission tomographic (PET) and computed tomo-
graphic (CT) imaging was undertaken as described in Van der
Veen et al, 2012 [9]. Mice (2–4.5 months) were fasted for 5 hrs
prior to PET and CT scanning. After being anesthetized with
1.5% isoflurane, they were injected retro-oribitally with ,200 mCi
of (18F)-flurodeoxyglucose [FDG (Spectron MRC, South Bend,
IN)] and returned to their cages. The mice were active within
2 mins after the light anesthesia. 30 mins after the injection, the
mice were re-anesthetized and the PET and CT images were
acquired on a trimodal Albira PET/SPECT/CT image station
(Bruker Molecular Imaging, Billerica, MA). All procedures were
performed between ZT6 and ZT10. High density PET (voxel size
0.6560.6560.944 mm [xyz]) and CT (voxel size 250 Hounsfield
units) images were reconstructed and fused, volumes of interest
(VOI) of relevant tissues were delineated and their FDG uptake
was quantified using PMOD version 3.2 (PMOD Technologies,
Zurich, Switzerland). The data of FDG uptake activity from the
microPET images were expressed as standard uptake value (SUV)
representing the average FDG uptake activity (mean voxel value)
in each VOI (in kilo Becquerel per cubic centimeter) divided by
injected dose of radioactivity (in Mega Becquerel) per kilogram of
animal weight. For skeletal muscle we calculated the SUV from
both the mean and maximum voxel values. The volumes of
interest for brain and forelimb skeletal muscle were determined by
manually contouring the tissue based on CT. For heart the VOIs
were first delineated manually by contouring the FDG uptake
activity that was clearly above the background activity followed by
delineating a second VOI based on a threshold equal to 60% of
the FDG uptake activity within the first, and the SUV of the
second VOI is reported. Similarly the initial VOIs of the iBAT
were delineated manually by keeping the heat bar to a fixed value
to minimize inter-individual subjective bias, and the FDG uptake
activity of this VOI is reported. To determine activated iBAT
volume, a second VOI was selected based on a threshold equal to
the average FDG uptake activity minus one standard deviation
within the initial VOI, and the volume of this new VOI is used to
report the activated iBAT volume [66].
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Histology
Gonadal WAT and iBAT were excised from older mice (10–26
months), embedded in OCT compound and frozen. Sections of
8 mm thickness were cut and stored at room temperature
overnight for drying followed by fixation using chilled acetone
method. The slides were then stained with Hematoxylin and
Eosin. For lipid analysis the slides were stained in a working
solution of Oil Red O (Sigma Aldrich) for 10 mins and then
counterstained in Mayer’s Hematoxylin. Multiple images at
206magnification were captured from each section using a Nikon
90i wide field microscope with a Nikon DS-Fi1 digital camera.
Three to 7 sections from each individual were quantified. The
images were analyzed manually using NIH ImageJ software. For
WAT, the outline of each cell was drawn manually and area
measured in pixels, and then converted to mm2 [67]. For iBAT
lipid analysis the images were RGB stacked in ImageJ and the
green channel was selected to measure the area covered by Oil
Red O stain.
Skeletal Muscle Lipid Analysis
Tibialis anterior were collected from mice (3–12 months) at
ZT3-4 on liquid nitrogen and tissue samples analyzed for TG and
DAG content by chloroform-methanol (containing butylated
hydroxytoluene) extraction and liquid chromatography-mass
spectrometry at the National Mouse Metabolic Phenotyping
Center (MMPC) at Yale University School of Medicine (New
Haven, CT).
Statistics
Data were analyzed in Sigma Plot 12.0 software using two-
factor ANOVA or two-factor repeated measures (RM) ANOVA
with genotype, sex or age as the independent variables. The data
that were non-normal and heteroscedastic were transformed to
ranks (behavioral data), natural logarithms or square root values,
before analysis. When ANOVA revealed a significant interaction
between factors, Tukey’s post hoc tests were conducted. Student’s t
test was used to compare two groups. The relationship between
variables was analyzed using Spearman’s rank order correlation
test or linear regression. The value of a was set at ,0.05.
Supporting Information
Figure S1 Id22/2males show more alterations in their
circadian behavioral pattern than in their daily behav-
ioral pattern, while alterations in behavioral patterns of
Id22/2 females are consistent under circadian and
daily conditions. A–E, males; F–K, females. A) Daily feeding
activity profile of male WT and Id22/2 mice (ANOVA: time,
P,0.001; genotype, P= 0.067; interaction, n.s.). B) Circadian
feeding activity profile of male mice (time, P,0.001; genotype,
P = 0.121; interaction, n.s.). C) Daily passive infrared (PIR) motion
detector general activity profile of male mice (time, P,0.001;
genotype, P,0.01; interaction, n.s.). D) Circadian general activity
profile of male mice (time, P,0.001; genotype, P,0.01;
interaction, P,0.001). E) Daily wheel running activity profile of
male mice (time, P,0.001; genotype, P,0.001; interaction,
P = 0.233). F) Daily feeding activity profile of female mice
(ANOVA: time, P,0.001; genotype, n.s.; interaction, P,0.01).
G) Circadian feeding activity profile of female mice (time,
P,0.001; genotype, n.s.; interaction, n.s.). H) Daily general
activity profile of female mice (time, P,0.001; genotype, n.s.;
interaction, P,0.001). I) Circadian general activity profile of
female mice (time, P,0.001; genotype, n.s.; interaction, P,0.01).
J) Daily wheel running activity profile of female mice (time,
P,0.001; genotype, P,0.001; interaction, P,0.001). K) Circadi-
an wheel running activity profile of female mice (time, P,0.001;
genotype, P,0.01; interaction, P,0.05). The shaded area in the
plots represents dark phase of the LD cycle or constant darkness.
Values shown represent mean 6 SEM. *p,0.05, **p,0.01 and
***p,0.001.
(TIF)
Figure S2 Weight gain and food consumption pattern of
Id22/2 mice. A) Weekly weight gain pattern of Id22/2 and
WT mice in standard cages (ANOVA: genotype, n.s.; sex, n.s;
interaction, n.s.). B) Daily food intake of Id22/2 and WT mice in
standard cages (genotype, n.s.; sex, P= 0.076; interaction,
P,0.05). C) Food consumption of Id22/2 and WT mice in
standard cages during dark phase of LD cycle (genotype, n.s.; sex,
n.s.; interaction, P,0.05). D) Food consumption of Id22/2 and
WT mice in standard cages during light phase of LD cycle
(genotype, n.s; sex, n.s.; interaction, n.s.). E) Food consumption of
Id22/2 and WT mice in cages equipped with a running wheel,
during dark phase of LD cycle (genotype, n.s; sex, P,0.001;
interaction, P,0.01). F) Food consumption of Id22/2 and WT
mice in wheel cages during light phase of LD cycle (genotype, n.s.;
sex, P= 0.086; interaction, n.s.). Values shown represent mean 6
SEM. *p,0.05, **p,0.01 and ***p,0.001.
(TIF)
Figure S3 Insulin ELISA levels in aged animals at 2 min
following glucose-treatment. A) Insulin levels of old male WT
and Id22/2 mice (t-test, n.s.). B) Insulin levels of old female WT
and Id22/2 mice (n.s.). No significant effect of genotype or sex
were detected for the insulin measurements when males and
females were group analyzed (ANOVA: genotype, P,0.061; sex,
P,0.075; interaction P,0.251), although there was a tendency for
Id22/2 mice to have lower insulin levels. Values shown represent
mean 6 SEM.
(TIF)
Figure S4 Quantitative analysis of FDG uptake. A) FDG
uptake in the brain of WT and Id22/2 mice (ANOVA: genotype,
n.s.; sex, n.s.; interaction, n.s.). B) FDG uptake in the heart of WT
and Id22/2 mice (genotype, n.s.; sex, n.s.; interaction, n.s.). C)
FDG uptake in the forelimb skeletal muscle of WT and Id22/2 as
SUV (from maximum voxel value) (genotype, P,0.01; sex,
P,0.05; interaction, P= 0.074). D) Body weight comparison
between WT and Id22/2 mice of mice used for FDG-PET
analysis (ANOVA: genotype, P,0.05; sex, P,0.01; interaction,
P,0.05). Values shown represent mean 6 SEM. *p,0.05,
**p,0.01 and ***p,0.001.
(TIF)
Figure S5 Id22/2 males have reduced interscapular
brown adipose tissue lipid deposits. A) Comparison of
iBAT weight of WT and Id22/2 mice (ANOVA: genotype, n.s.;
sex, P= 0.03 P,0.05; interaction, P = 0.031 P,0.05). B) Repre-
sentative images of Hematoxylin/eosin (H/E) stained and Oil Red
O stained iBAT sections from male WT and Id22/2 mice (scale
bar = 50 mm). C) Quantitative analysis of Oil Red O staining
represented as percentage area fraction (genotype, n.s.; sex,
P,0.05; interaction, P,0.01). C). Values shown represent mean
6 SEM. *p,0.05, **p,0.01 and ***p,0.001.
(TIF)
Figure S6 Body mass and gonadal WAT deposit mass of
Id22/2 mice used for skeletal muscle lipid analysis. A)
Body weight comparison between WT and Id22/2 mice
(ANOVA: genotype, P,0.001; sex, P,0.01; interaction,
P,0.05). B) WAT mass of Id22/2 and WT mice as a proportion
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of body weight (ANOVA: genotype, P,0.01; sex, n.s.; interaction,
n.s.). Values shown represent mean 6 SEM. *p,0.05, **p,0.01
and ***p,0.001.
(TIF)
Results S1.
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